JP2008526935A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526935A5
JP2008526935A5 JP2007550830A JP2007550830A JP2008526935A5 JP 2008526935 A5 JP2008526935 A5 JP 2008526935A5 JP 2007550830 A JP2007550830 A JP 2007550830A JP 2007550830 A JP2007550830 A JP 2007550830A JP 2008526935 A5 JP2008526935 A5 JP 2008526935A5
Authority
JP
Japan
Prior art keywords
use according
drug
intended
wound
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007550830A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526935A (ja
Filing date
Publication date
Priority claimed from GBGB0500643.2A external-priority patent/GB0500643D0/en
Application filed filed Critical
Publication of JP2008526935A publication Critical patent/JP2008526935A/ja
Publication of JP2008526935A5 publication Critical patent/JP2008526935A5/ja
Pending legal-status Critical Current

Links

JP2007550830A 2005-01-13 2006-01-06 創傷治癒のためのil−10関連ペプチド Pending JP2008526935A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0500643.2A GB0500643D0 (en) 2005-01-13 2005-01-13 Medicaments
PCT/GB2006/000051 WO2006075138A2 (en) 2005-01-13 2006-01-06 Il-10 related peptides for wound healing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012165481A Division JP2012211185A (ja) 2005-01-13 2012-07-26 創傷治癒のためのil−10関連ペプチド

Publications (2)

Publication Number Publication Date
JP2008526935A JP2008526935A (ja) 2008-07-24
JP2008526935A5 true JP2008526935A5 (https=) 2009-02-26

Family

ID=34224534

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007550830A Pending JP2008526935A (ja) 2005-01-13 2006-01-06 創傷治癒のためのil−10関連ペプチド
JP2012165481A Pending JP2012211185A (ja) 2005-01-13 2012-07-26 創傷治癒のためのil−10関連ペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012165481A Pending JP2012211185A (ja) 2005-01-13 2012-07-26 創傷治癒のためのil−10関連ペプチド

Country Status (7)

Country Link
US (3) US20080139478A1 (https=)
EP (2) EP1858544B1 (https=)
JP (2) JP2008526935A (https=)
AU (1) AU2006205696C1 (https=)
CA (1) CA2594798A1 (https=)
GB (1) GB0500643D0 (https=)
WO (1) WO2006075138A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments
EP2091557A2 (en) * 2006-11-15 2009-08-26 Coda Therapeutics, INC. Improved methods and compositions for wound healing
BR112012000353B1 (pt) 2009-07-06 2020-06-02 Astrazeneca Ab Composto de fórmula markush, uso do composto, processos de reação com agente de acetilação e processo para preparação de um composto
EP2691515A2 (en) * 2011-03-31 2014-02-05 President and Fellows of Harvard College A unique population of regulatory t cells that regulate tissue regeneration and wound healing
US9724448B2 (en) * 2013-03-14 2017-08-08 3-D Matrix, Ltd. Materials for gastrointestinal obstruction prevention
MX2015014438A (es) 2013-04-18 2016-05-18 Armo Biosciences Inc Metodos de uso de interleucina-10 para tratar enfermedades y trastornos.
EP3010527B1 (en) 2013-06-17 2018-08-08 Armo Biosciences, Inc. Method for assessing protein identity and stability
US10098929B2 (en) 2013-08-02 2018-10-16 Children's Hospital Medical Center Method of reducing scar formation in healing of dermal wounds by administering interleukin-10 and hyaluronan
CN105658232A (zh) 2013-08-30 2016-06-08 阿尔莫生物科技股份有限公司 使用白细胞介素-10治疗疾病和病症的方法
CN120242030A (zh) 2013-11-11 2025-07-04 阿尔莫生物科技股份有限公司 将白细胞介素-10用于治疗疾病和病症的方法
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
WO2016060996A2 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
AU2015336101A1 (en) 2014-10-22 2017-04-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US20160361415A1 (en) 2015-05-28 2016-12-15 Armo Biosciences, Inc. Methods of Using Interleukin-10 for Treating Diseases and Disorders
KR20180038553A (ko) 2015-08-25 2018-04-16 아르모 바이오사이언시스 인코포레이티드 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217857B1 (en) * 1989-06-28 2001-04-17 Schering Corporation Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof
AU686816B2 (en) * 1994-07-05 1998-02-12 Steeno Research Group A/S Immunomodulators
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
AU4385696A (en) * 1996-01-18 1997-08-11 Christian Gronhoj Larsen Synthetic il-10 analogues
GB0500643D0 (en) 2005-01-13 2005-02-23 Renovo Ltd Medicaments

Similar Documents

Publication Publication Date Title
JP2008526935A5 (https=)
AU2002334886B2 (en) Methods and compositions for treating dermal lesions
ES2389285T3 (es) Péptidos bioactivos cortos y procedimientos para su uso
JP2012506442A5 (https=)
US20100144618A1 (en) Compositions containing an intestinal trefoil peptide and a mucoadhesive
JP2005516885A5 (https=)
HRP20140616T1 (hr) Peptidni analog oksintomodulina
US7538082B2 (en) Methods and compositions for treating oral and esophageal lesions
SA110310710B1 (ar) عوامل مساعدة لمستقبل أوكسيتوسين
WO1999006440A8 (en) Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome
BR9607336A (pt) Composições de aminoácidos e utilidades das mesmas em nutrição clinica
WO2011156453A3 (en) Therapeutic peptides
TWI305778B (en) Peptides of an expressing unit for igf-i minimal activity and their pharmaceutical use
WO2003018049A3 (en) Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
NO20062198L (no) Bradykinin B1 reseptorantagonister
CA2825246A1 (en) Human lactoferrin based peptides having anti-inflammatory activity
WO2024169972A1 (en) New multi-functional oligopeptides
JP2009535330A5 (https=)
CA2952475A1 (en) Vip fragment for the treatment of myocardial fibrosis
JP2004538320A5 (https=)
CN105451756A (zh) 在治疗马凡氏综合征及其相关病症中的血管紧张素肽
CA2423004A1 (en) Peptide inhibitors of hiv entry
EP2205270A1 (en) Peptides based on the sequence of human lactoferrin and their use
US8217011B2 (en) Peptides, compositions and uses thereof
US8853359B2 (en) Endokinin C/D-derived peptides